Attempts to generate GCN2 KO NCI-H358 cells using CRISPR/Cas9 gene editing were unsuccessful; however, knockout of GCN2 was successful in HCT116 colorectal cancer cells (Fig. 5B–H). This evidence concerns the gene EIF2AK4 and colorectal cancer.